1 recruiting, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Colistimethate Sodium for Injection: new trials by email Literature Review of Colistimethate Sodium for Injection trials Research Report on Colistimethate Sodium for Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria TQD3524, Meropenem for injection, Colistimethate Sodium for Injection - Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia | Phase 2 | Recruiting | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 48 | 2026-07-21 | 2026-09-04 |
| A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection Colistimethate sodium for injection, Meropenem for Injection, Coly Mycin M Injectable Product - Mental Health Issue | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 80 | 2023-07-06 | 2024-01-10 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (2)
China (2)